Neoplasm Metastasis: all 3,564 studies

Page 36 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.CompletedNCT00035035Phase 3
• This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast CancerCompletedNCT00034918Phase 2
• Iressa Expanded Access Program (EAP)CompletedNCT00034879Phase 3
• Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)TerminatedNCT00034697Phase 2
• ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic CancerCompletedNCT00034463Phase 1
• ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00034346Phase 2
• Study of Noni in Cancer PatientsCompletedNCT00033878Phase 1
• Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesCompletedNCT00030628Phase 3
• ADI-PEG in Patients With Metastatic MelanomaCompletedNCT00029900Phase 1
• Radiofrequency Ablation in Relieving Pain in Patients With Bones MetastasesCompletedNCT00029029Phase 2
• Interleukin-12 Gene Therapy in Treating Patients With Skin MetastasesTerminatedNCT00028652Phase 1
• Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal CancerCompletedNCT00028626Phase 2
• Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid TumorsCompletedNCT00028405Phase 1
• Radiofrequency Ablation in Treating Patients With Bone MetastasesCompletedNCT00026247Not applicable
• Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
• Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & LymphomasTerminatedNCT00023166Phase 1
• Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00021164Phase 2
• Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverCompletedNCT00019760Phase 2
• Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedNCT00019695Phase 2
• 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic CancerCompletedNCT00016874Phase 1
• Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the LiverCompletedNCT00012155Phase 1
• Temozolomide in Treating Patients With Solid Tumors That Have Spread to the BrainCompletedNCT00012116Phase 2
• Study of Lung Function in Children Who Have Undergone Bone Marrow TransplantationCompletedNCT00009711
• Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00008294Phase 1
• Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerStatus unknownNCT00006479Phase 3
• Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid TumorsCompletedNCT00006456Phase 2
• Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and MetastasesCompletedNCT00006255Phase 2
• Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
• Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or LymphomaTerminatedNCT00005812Phase 2
• Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium BacteriaCompletedNCT00004988Phase 1
• Biological Therapy in Treating Patients With Metastatic CancerCompletedNCT00004604Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00003753Phase 2
• Conventional or Video-Assisted Surgery in Treating Patients With Lung MetastasesCompletedNCT00003724Phase 3
• Immunotherapy in Treating Patients With Resected Liver Metastases From Colon CancerCompletedNCT00003433Phase 1/2
• Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain MetastasesCompletedNCT00003324Not applicable
• Radiation Therapy Following Surgery to Remove Brain MetastasesCompletedNCT00003320Not applicable
• Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerCompletedNCT00003162Phase 3
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the CervixCompletedNCT00003065Phase 2
• Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00002997Phase 2
• Adjuvant Radiation Therapy in Treating Patients With Brain MetastasesTerminatedNCT00002899Phase 3
• Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal CancerStatus unknownNCT00002793Phase 3
• Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaCompletedNCT00002764Phase 3
• Monoclonal Antibody Therapy in Treating Patients With Brain MetastasesCompletedNCT00002751Phase 1/2
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00002716Phase 3
• Oxaliplatin in Cancer Patients With Impaired Kidney FunctionCompletedNCT00001835Phase 1
• Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal SequenceCompletedNCT00001705Phase 2
• Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseCompletedNCT00001685Phase 2
• A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic CancerCompletedNCT00001683Phase 1
• A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the LiverCompletedNCT00001587Phase 1
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the LiverCompletedNCT00001576Phase 1
• A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal CancerCompletedNCT00001570Phase 1
• Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast CancerCompletedNCT00001507Phase 1
• Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast CancerCompletedNCT00001493Phase 2
• Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive ChemotherapyCompletedNCT00001440Phase 1
• A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With OsteosarcomaCompletedNCT00001436Phase 1
• Direct Injection of Alcohol for the Treatment of Spinal TumorsCompletedNCT00001417
• Gene Therapy for the Treatment of Brain TumorsCompletedNCT00001328Phase 1
• A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833CompletedNCT00001302Phase 1
• Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and LymphomaCompletedNCT00001270Phase 1
• Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast CancerCompletedNCT00001269Phase 1
• Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized TrialCompletedNCT00001250Phase 2
• A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast CancerCompletedNCT00001193Phase 2
• Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the PancreasCompletedNCT00001165Phase 2

← Neoplasm Metastasis overview